ARCHIVES

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

USC wins $3.5 million NCI grant.

April 23, 2004

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Final Issues Of 1982

December 10, 1982

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992